171 related articles for article (PubMed ID: 14639890)
1. HIV-associated neuropathies. Not a necessary consequence of HIV infection.
Baker WC
Adv Nurse Pract; 2003 Nov; 11(11):83-6, 89-90. PubMed ID: 14639890
[No Abstract] [Full Text] [Related]
2. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy.
Simpson DM
J Neurovirol; 2002 Dec; 8 Suppl 2():33-41. PubMed ID: 12491149
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy in HIV disease.
Markarian Y; Wulff EA; Simpson DM
AIDS Clin Care; 1998 Dec; 10(12):89-91, 93, 98. PubMed ID: 11366069
[TBL] [Abstract][Full Text] [Related]
4. Markers of immune activation and viral load in HIV-associated sensory neuropathy.
Schifitto G; McDermott MP; McArthur JC; Marder K; Sacktor N; McClernon DR; Conant K; Cohen B; Epstein LG; Kieburtz K;
Neurology; 2005 Mar; 64(5):842-8. PubMed ID: 15753420
[TBL] [Abstract][Full Text] [Related]
5. HIV infection of the central nervous system: clinical features and neuropathogenesis.
Boissé L; Gill MJ; Power C
Neurol Clin; 2008 Aug; 26(3):799-819, x. PubMed ID: 18657727
[TBL] [Abstract][Full Text] [Related]
6. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
7. Relationship of neurological manifestations, CD4+ lymphocyte count and plasma viral load in HIV infected patients.
Gochitashvili N; Tsertsvadze T; Gatserelia L; Abashidze L; Sharvadze L
Georgian Med News; 2005 Apr; (121):51-5. PubMed ID: 15908725
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral rounds. CD4 count 423, viral load 12,000: time to treat anyway?
Hodder S; Frank I
AIDS Clin Care; 2006 Jun; 18(6):59-60. PubMed ID: 16791955
[No Abstract] [Full Text] [Related]
9. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.
Kofoed K; Gerstoft J; Mathiesen LR; Benfield T
Sex Transm Dis; 2006 Mar; 33(3):143-8. PubMed ID: 16505739
[TBL] [Abstract][Full Text] [Related]
10. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
[TBL] [Abstract][Full Text] [Related]
11. [Peripheral nerve diseases and myopathies associated with HIV infection].
Nervenarzt; 2000 Jun; 71(6):442-50. PubMed ID: 10919138
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
13. HIV type 2 demyelinating encephalomyelitis.
Moulignier A; Lascoux C; Bourgarit A
Clin Infect Dis; 2006 Jun; 42(11):e89-91. PubMed ID: 16652302
[TBL] [Abstract][Full Text] [Related]
14. [Infectious neuropathies].
Créange A
Rev Prat; 2000 Apr; 50(7):743-8. PubMed ID: 10853554
[TBL] [Abstract][Full Text] [Related]
15. Therapy for early HIV infection: how far back should the pendulum swing?
Schechter M
J Infect Dis; 2004 Sep; 190(6):1043-5. PubMed ID: 15319851
[No Abstract] [Full Text] [Related]
16. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
[TBL] [Abstract][Full Text] [Related]
17. HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.
Jaafar A; Massip P; Sandres-Sauné K; Souyris C; Pasquier C; Aquilina C; Izopet J
J Med Virol; 2004 Sep; 74(1):8-15. PubMed ID: 15258962
[TBL] [Abstract][Full Text] [Related]
18. [Why antiretroviral therapy must not begin to early?].
Valantin MA; Katlama C
Rev Prat; 2004 Apr; 54(8):819-24. PubMed ID: 15274451
[No Abstract] [Full Text] [Related]
19. Focus on hepatitis. HIV/HCV coinfection and ART.
Carter M
IAPAC Mon; 2006 May; 12(5):157. PubMed ID: 17249142
[No Abstract] [Full Text] [Related]
20. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.
Lichtenstein KA; Armon C; Baron A; Moorman AC; Wood KC; Holmberg SD;
Clin Infect Dis; 2005 Jan; 40(1):148-57. PubMed ID: 15614705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
